That press release was quite artfully crafted.
The initial 275 (P-1?) patients delivered descriptive data only regarding virus loads; the next 524 (P-2?) confirmed better viral load reduction than placebo. These #s were way significant - the drug cloaks the virus spike all right.
What I wanted to know was what was the actual percentage of viral load drop. It may have done better against placebo but it might not have been that great if the viral load drop for placebo was small.